TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/29/24 16:17 | 4/28/24 | LXRX | Lexicon Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Debbane Raymond | TX | D | M.d | 0 | 0.00 | 0 | 8 | 0 | 6,800 | D | |||||||||||||||
10/12/23 16:01 | 10/10/23 | LXRX | Lexicon Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Debbane Raymond | TX | D | P.m | 1,104 | 1.10 | 0 | 1,000 | 17 | 6,792 | D | |||||||||||||||
5/22/23 16:03 | 5/21/23 | LXRX | Lexicon Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Debbane Raymond | TX | D | M.d | 0 | 0.00 | 0 | 9 | 0 | 5,792 | D | |||||||||||||||
11/15/22 17:26 | 11/10/22 | WW | Ww International, Inc. | VA | PerSv | PerSv | Personal Services | Debbane Raymond | NY | D | P | 320 | 4.27 | 0 | 75 | 146 | 126 | D | |||||||||||||||
8/1/22 16:13 | 8/1/22 | LXRX | Lexicon Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Debbane Raymond | TX | D | P | 2,457 | 2.50 | 0 | 983 | 21 | 5,635 | I | |||||||||||||||
5/2/22 16:14 | 4/30/22 | LXRX | Lexicon Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Debbane Raymond | TX | D | M.d | 0 | 0.00 | 0 | 4 | 0 | 4,653 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |